Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioArctic AB Class B (DE:B9A)
FRANKFURT:B9A
RESEARCH TOOLSreports
Holding DE:B9A?
Track your performance easily
B9A Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€11.94 - €24.84
Previous Close€16.39
Volume0.00
Average Volume (3M)101.00
Market Cap
€1.44B
Enterprise Value€1.37B
Total Cash (Recent Filing)kr863.16M
Total Debt (Recent Filing)kr10.16M
Price to Earnings (P/E)―
Beta0.61
Next Earnings
Feb 13, 2025EPS Estimate
-€0.06Last Dividend Ex-Date
May 10, 2019Dividend YieldN/A
Share Statistics
EPS (TTM)-0.23
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume101
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)90.09
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioArctic AB Class B News
PremiumPre-Earnings
Is B9A a Buy, Before Earnings?
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.93% Mutual Funds
― Other Institutional Investors
96.41% Public Companies and
Individual Investors
B9A FAQ
What was BioArctic AB Class B’s price range in the past 12 months?
BioArctic AB Class B lowest stock price was €11.94 and its highest was €24.84 in the past 12 months.
What is BioArctic AB Class B’s market cap?
Currently, no data Available
When is BioArctic AB Class B’s upcoming earnings report date?
BioArctic AB Class B’s upcoming earnings report date is Feb 13, 2025 which is in 78 days.
How were BioArctic AB Class B’s earnings last quarter?
BioArctic AB Class B released its earnings results on Nov 14, 2024. The company reported -€0.019 earnings per share for the quarter, beating the consensus estimate of -€0.054 by €0.035.
Is BioArctic AB Class B overvalued?
According to Wall Street analysts BioArctic AB Class B’s price is currently Overvalued.
Does BioArctic AB Class B pay dividends?
BioArctic AB Class B pays a Notavailable dividend of €0.13 which represents an annual dividend yield of N/A. See more information on BioArctic AB Class B dividends here
What is BioArctic AB Class B’s EPS estimate?
BioArctic AB Class B’s EPS estimate is -€0.06.
How many shares outstanding does BioArctic AB Class B have?
BioArctic AB Class B has 73,659,990 shares outstanding.
What happened to BioArctic AB Class B’s price movement after its last earnings report?
BioArctic AB Class B reported an EPS of -€0.019 in its last earnings report, beating expectations of -€0.054. Following the earnings report the stock price went up 7.552%.
Which hedge fund is a major shareholder of BioArctic AB Class B?
Currently, no hedge funds are holding shares in DE:B9A
---
BioArctic AB Class B Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.20%
12-Months-Change
Fundamentals
Return on Equity
-22.71%
Trailing 12-Months
Asset Growth
-10.53%
Trailing 12-Months
Company Description
BioArctic AB Class B
BioArctic AB is a research-based biopharmaceutical company. It is primarily focused on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of revenue from Asia.
---
Technical Analysis
---